期刊文献+

丙基戊酸钠对宫颈癌细胞HeLa增殖的影响机制 被引量:3

The mechanisms of sodium valproate on cell proliferation inhibition in cervical cancer cell line HeLa.
下载PDF
导出
摘要 目的:探讨组蛋白去乙酰化酶抑制剂(histone deacetylase inhibitor,HDACI)丙基戊酸钠(sodium valproate,VPA)影响宫颈癌细胞HeLa增殖的机制。方法:用MTT法检测不同浓度VPA对HeLa细胞增殖的影响;倒置相差显微镜观察药物作用后细胞形态的变化;流式细胞仪(FCM)分析不同浓度VPA对HeLa细胞凋亡及细胞周期的影响;Western blot观察不同浓度VPA处理后caspase-3、bcl-2蛋白的表达变化。结果:VPA能明显抑制HeLa细胞的增殖,并呈时间和剂量依赖关系;经4mmol/L VPA处理48h后,HeLa细胞缩小变形成长梭状、胞膜皱缩、贴壁不良;VPA诱导HeLa凋亡、阻滞细胞于G2/M期,同时抑制细胞增殖;随浓度增加,VPA能明显增加caspase-3蛋白表达,并可见到蛋白裂解产物,表明VPA可以促进caspase-3活化,但下调bcl-2蛋白的表达。结论:VPA有抗宫颈癌作用,其重要作用机制之一是诱导HeLa细胞凋亡、直接抑制细胞增殖,有望成为新的抗宫颈癌药物。 Objective:To investigate the mechanisms of histone deaeetylase inhibitor sodium valproate on cell proliferation in cervical cancer cell line HeLa. Methods:Effect of VPA in various concentrations on proliferation of HeLa cells was detected by MTT;morphologic changes of HeLa cells were observed by inverted phase contrast microscope;flow cytometry was used to determine the effects of VPA on apoptosis and cell cycle distribution. The level of caspase-3 and bcl-2 protein expression was assayed by western blot. Results:The changes of the growth curve showed VPA inhibited the proliferation of HeLa cells significantly in time and dose dependent manner,after a 48 hours culture with 4mmol/L VPA,the cells exhibited deflate ,the cell membrane shrinkage and bad adherence. VPA not only induced apoptosis and caused cell cycle arrest at G2/M phase,but also inhibited the proliferation of HeLa cells. The expression of caspase-3 protein increased after treatment with VPA at a dose-dependent manner, whereas bcl-2 was down regulated. Western blot also showed cleaved caspase-3 ,which represents the activation of caspase-3. Conclusion:VPA can inhibit cervical cancer in vitro through inducing apoptosis and inhibiting cell proliferation directly. The results of this study suggest that histone deacetylase inhibitors axe hopeful to become new drugs to treat cervical cancer.
机构地区 山东大学医学院
出处 《现代妇产科进展》 CSCD 北大核心 2008年第4期277-280,共4页 Progress in Obstetrics and Gynecology
关键词 宫颈肿瘤 HELA细胞 细胞系 组蛋白去乙酰化酶抑制剂 丙基戊酸钠 细胞增殖 Cervix neoplasms HeLa cells Cell line Histone deacetylase inhibitor Sodium valproate Cell proliferation
  • 相关文献

参考文献14

  • 1Sakajiri S, Kumagai T, Kawamata N, et al. Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines [ J ]. Exp Hematol,2005,33 : 53- 61
  • 2Hsi LC,Xi X,Lotan R,et al. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-1ipoxygenase-1 in colorectal cancer cells[ J]. Cancer Res ,2004,64:8778-8781
  • 3Gottlicher M. Valproic acid:an old newly discovered as inhibitor of histone deacetylases [ J ]. Ann Hematol, 2004, 83 :$91-92
  • 4Johnstone RW. Histone-deacetylase inhibitors:novel drugs for the treatment of cancer [ J ]. Nat Rev Drug Discov, 2002,1 : 287-299
  • 5Children's Oncology Group,Fouladi M,Furman WL,et al. Phase Ⅰ study of depsipeptide in pediatric patients with refractory solid tumors:a Children's Oncology Group report [ J ]. J Clin Oncol,2006,24 : 3678-3685
  • 6Zhang Y ,Jung M, Dritschilo A, et al. Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors [ J ]. Radiat Res, 2004,161:667-674
  • 7Shabbeer S, Kortenhorst MS, Kachhap S, et al. Multiple molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo [ J]. Prostate,2007,67:1099-1110
  • 8Kaiser M,Zavrski I, Sterz J, et al. The effects of the histone deacetylase inhibitor valproic acid on cell cycle, growth suppression and apoptosis in multiple myeloma [ J ]. Haematologica,2006,91 : 248-251
  • 9Munshi A, Tanaka T, Hobbs ML, et al. Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci [ J ]. Mol Cancer Ther, 2006, 5 : 1967-1974
  • 10Schwartz C,Palissot V,Aouali N,et al. Valproic acid induces non-apoptotic cell death mechanisms in multiple myeloma cell lines [ J ]. Int J Oncol,2007 ,30 :573-582

二级参考文献30

  • 1许沈华,余传定,牟瀚舟,姜志明,朱赤红,刘祥麟.用基因芯片筛选胃黏膜癌变相关基因[J].中华胃肠外科杂志,2006,9(5):436-440. 被引量:6
  • 2Strahl BD, Allis CD. The language of covalent histone modifications.Nature, 2000, 403 (6765): 41-45.
  • 3Marks P, Rifkind RA, Richon VM, et al. Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer,2001,1 (3):194-202.
  • 4Gurvich N, Tsygankova OM, Meinkoth JL, et al. Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Res, 2004, 64(3) :1079-1086.
  • 5Thelen P, Schweyer S, Hemmerlein B, et al. Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells. Int J Oncol, 2004, 24 (1) :25-31.
  • 6Gottlicher M, Minucci S, Zhu P,et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells.EMBO J, 2001, 20(24): 6969-6978.
  • 7Takai N, Desmond JC, Kumagai T,et al. Histone Deacetylase Inhibitors Have a Profound Antigrowth Activity in Endometrial Cancer Cells . Clin Cancer Res, 2004, 10(3) :1141-1149.
  • 8Burgess AJ, Pavey S, Warrener R, et al. Up-regulation of p21(WAF1/CIP1) by histone deacetylase inhibitors reduces their cytotoxicity. Mol Pharmacol, 2001, 60(4) :828-837.
  • 9Nakata S, Yoshida T, Horinaka M, et al. Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells. Oncogene ,2004, 23 ( 37 ) :6261-6271.
  • 10Rosato RR, Almenara JA, Grant S. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1. Cancer Res, 2003, 63 (13):3637-3645.

共引文献5

同被引文献43

  • 1LV Yuyin,YIN Chunsheng,LIU Hongyan,YI Zhongsheng,WANG Yang.3D-QSAR study on atmospheric half-lives of POPs using CoMFA and CoMSIA[J].Journal of Environmental Sciences,2008,20(12):1433-1438. 被引量:7
  • 2时昌文,李杰,赵霞,曹莉莉,孙京杰.丙戊酸钠对肝癌细胞系HepG2的生长抑制作用[J].中华肿瘤防治杂志,2007,14(7):510-513. 被引量:12
  • 3Batty N, Malouf GG, Issa JP, et al. Histone deacetylase in- hibitors as anti-neoplastic agents [J]. Cancer Lett, 2009, 280 (2) :192.
  • 4Sawan C,Herceg Z. Histone modifications and cancer[J]. Adv Genet,2010,70:57.
  • 5Johnstone RW. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer [J]. Nat Rev Drug Discov, 2002,1:287.
  • 6Children's Oncology Group, Fouladi M, Furman WL, et al. Phase I study of depsipeptide in pediatric patients with re- fractory solid tumors:a Children "s Oncology Group report [J]. J Clin Onco:,2006 ,24 :3678.
  • 7Anton M, Horky M, Kucht:ckov6 S, et al. Immunohisto- chemical detection of acetylation and phosphorylation of histone H3 in cervical smears [J]. Ceska Gynekol, 2004, 69(1) :3.
  • 8Yugawa T, Kiyomo T. Molecular mechanisms of cervical c- arcinogenesis by high-risk human papilloma viruses:novel function of E6 and E7 oncoproteins[J]. Rev Med Virol, 2009,19 (2) :97.
  • 9Phiel CJ, Zhang F, Huang EY, et al. Histone deacetylase is a direct target of valproic acid, a potent anticon-vulsant, mood stabilizer, and teratogen[J]J Biol Chem, 2001,276 (39) :36734.
  • 10Gottlieher M, Minueci S ,Zhu P, et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells [ J ]. EMBO,2001,20 ( 24 ) :6969.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部